Isoniazid-resistant rifampicin-susceptible tuberculosis: study shows better treatment success with fluoroquinolone


  • The Lancet Pneumology
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and acquired rifampicin resistance if treated with first-line antituberculosis drugs. The aim of the study was to compare success, morta...